| 1 |
|
GENE THERAPY - Adenovirus-mediated expression of a mutant IkB kinase 2 inhibits the response of endothelial cells to inflammatory stimuli/
|
Oitzinger, W
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 2 |
|
GENE THERAPY - A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease/
|
Thomis, D C
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 3 |
|
GENE THERAPY - A gene therapy approach for treating T-cell-mediated autoimmune diseases/
|
Chen, C-C
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 4 |
|
GENE THERAPY - bMinor-globin messenger RNA accumulation in reticulocytes governs improved erythropoiesis in b thalassemic mice after crythropoietin complementary DNA electrotransfer in muscles/
|
Samakoglu, S
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 5 |
|
GENE THERAPY - Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia/
|
Tolba, K A
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 6 |
|
GENE THERAPY - Effects of CD2 locus control region sequences on gene expression by retroviral and lentiviral vectors/
|
Indraccolo, S
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 7 |
|
GENE THERAPY - Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype/
|
Nishimura, J
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 8 |
|
GENE THERAPY - Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA/
|
Nathwani, A C
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 9 |
|
GENE THERAPY - Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX/
|
Ge, Y
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 10 |
|
GENE THERAPY - Genetically modified bone marrow continuously supplies anti-inflammatory cells and suppresses renal injury in mouse Goodpasture syndrome/
|
Yokoo, T
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 11 |
|
GENE THERAPY - High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors/
|
Moreau-Gaudry, F
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 12 |
|
GENE THERAPY - High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors/
|
Salmon, P
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 13 |
|
GENE THERAPY - Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: Superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells/
|
Tendeloo, V F I Van
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 14 |
|
GENE THERAPY - Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34+ hematopoietic cells/
|
Rosenzweig, M
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 15 |
|
GENE THERAPY - Induction of stable prenatal tolerance to b-galactosidase by in utero gene transfer into preimmune sheep fetuses/
|
Tran, N D
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 16 |
|
GENE THERAPY - Integrated src kinase and costimulatory activity enhances signal transduction through single-chain chimeric receptors in T lymphocytes/
|
Geiger, T L
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 17 |
|
GENE THERAPY - In utero transplantation of fetal liver cells in the mucopolysaccharidosis type VII mouse results in low-level chimerism, but overexpression of b-glucuronidase can delay onset of clinical signs/
|
Casal, M L
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 18 |
|
GENE THERAPY - Lack of dominant-negative effects of a truncated gc on retroviral-mediated gene correction of immunodeficient mice/
|
Otsu, M
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 19 |
|
GENE THERAPY - Lack of neighborhood effects from a transcriptionally active phosphoglycerate kinase-neo cassette located between the murine b-major and b-minor globin genes/
|
Kaufman, R M
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 20 |
|
GENE THERAPY - Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells/
|
Woods, N-B
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
기사
(35)
